Login
Existing Account

Please login first to complete purchase/ quotation request, view custom order reports, or create favorites list.

Customer ID:
Password:
Stay Logged In


Forgot your Customer ID or Password?
New Account

Don't have an account with us yet? Please set up an account to place order or obtain customer services.

Assay Kits  >  Secretase Assay Kits  >>  SensoLyte® 520 TACE (α-Secretase) Activity Assay Kit *Fluorimetric*

Product Name SensoLyte® 520 TACE (α - Secretase) Activity Assay Kit *Fluorimetric*
Size 1 kit
Catalog # 72085
US$ $435
Description

TACE (tumor necrosis factor-alpha converting enzyme), α-secretase, or ADAM17 is a member of the ADAM family of proteases that contain both disintegrin and metalloprotease (catalytic) domains. This enzyme is involved in sperm-egg binding and fusion, muscle cell fusion, neurogenesis, modulation of Notch receptor and ligand processing, and processing of the pro-inflammatory cytokine, TNFα. TACE is currently being explored as a target for anti-inflammatory drugs. SensoLyte® 520 TACE Activity Assay Kit uses a 5-FAM (fluorophore) and QXL® 520 (quencher) labeled FRET peptide substrate for continuous measurement of enzyme activity. In the intact FRET peptide, the fluorescence of 5-FAM is quenched by QXL® 520. Upon cleavage of the FRET peptide by the active enzyme, the fluorescence of 5-FAM is recovered, and can be continuously monitored at excitation/emission = 490 nm/520 nm. With superior fluorescence quantum yield and longer emission wavelength, 5-FAM/QXL® 520 based FRET peptide has less interference from the autofluorescence of test compounds and cellular components and provides better assay sensitivity. The kit can be used to detect the activity of TACE or screen for TACE inhibitors. The assays are performed in a convenient 96-well format.

Kit size: 100 assays

Detailed Information Datasheet
Material Safety Data Sheets (MSDS)
Poster
Storage -20°C
Product Citations Xu, X. et al. (2014). MUC1 in Macrophage: Contributions to Cigarette Smoke–Induced Lung Cancer. Cancer Res 74, 460. doi: 10.1158/0008-5472.CAN-13-1713.
Menghini, R. et al. (2013). Expression of tissue inhibitor of metalloprotease 3 is reduced in ischemic but not neuropathic ulcers from patients with type 2 diabetes mellitus. Acta Diabetol. doi: 10.1007/s00592-013-0478-6.
Rao, S. et al. (2013). Spleen tyrosine kinase (Syk)-dependent calcium signals mediate efficient CpG-induced exocytosis of tumor necrosis factor α (TNFα) in innate immune cells. J Biol Chem 288, 12448. doi: 10.1074/jbc.M113.454405.
Akool, ES. et al. (2012). Cyclosporin A and tacrolimus induce renal Erk1/2 pathway via ROS-induced and metalloproteinase-dependent EGF-receptor signaling. Biochem Pharmacol. 83:286.
Jijon, HB. et al. (2012). The EGF receptor and HER2 participate in TNF-α-dependent MAPK activation and IL-8 secretion in intestinal epithelial cells. Mediat Inflamm 2012, 12 pages. doi: 10.1155/2012/207398
Marolda, R. et al. (2012). Substance P activates ADAM9 mRNA expression and induces α-secretase-mediated amyloid precursor protein cleavage. Neuropharmacology. 62:1954.
Schmidt, V. et al. (2012). Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer’s disease. EMBO 31,187.
Guma, M. et al. (2011). Constitutive intestinal NF-kB does not trigger destructive inflammation unless accompanied by MAPK activation. J Exp Med 208, 1889.
Yang, Y. et al. (2011). Inhibitor of metalloproteinases-3 mediates the death of immature oligodendrocytes via TNF-α/TACE in focal cerebral ischemia in mice. J Neuroinflam 8, 108.
Zhao, XQ. et al. (2011). CRP enhances soluble LOX-1 release from macrophages by activating TNF-alpha converting enzyme. J Lipid Res doi: 10.1194/jlr.M015156.
Hassemer, EL. et al. (2010). The waved with open eyelids (woe) locus is a hypomorphic mouse mutation in Adam17. Genetics 185, 245.
Cardellini, M. et al. (2009). TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes 58, 2396.
Fiorentino, L. et al. (2009). Increased tumor necrosis factor -converting enzyme activity induces insulin resistance and hepatosteatosis in mice. Hepatology 51, 103.
Hurst, LA. et al. (2009). Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatment. J Neuroimmunol 210, 108.
Walker, EJ. et al. (2009). TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia. Exp Neuro 216, 122.
Tissue inhibitor of metalloproteinases-3 mediates the death of immature oligodendrocytes via TNF-α/TACE in focal cerebral ischemia in mice.
Oguma, T. et al. (2011). Induction of Mucin and MUC5AC Expression by the Protease Activity of Aspergillus fumigatus in Airway Epithelial Cells. J. Immunol 187:999.
Takasugi, N. et al. (2011). BACE1 Activity Is Modulated by Cell-Associated Sphingosine-1-Phosphate. J. Neurosci 31:6850.
Cardellini, M. et al. (2011). Decreased IRS2 and TIMP3 Expression in Monocytes From Offspring of Type 2 Diabetic Patients Is Correlated With Insulin Resistance and Increased Intima-Media Thickness. Diabetes 60:3265.
Stöhr, O. et al. (2011). Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer's disease. Age (Dordr). Nov 6. [Epub ahead of print]
     
  < Back